1. Home
  2. LEXX vs VATE Comparison

LEXX vs VATE Comparison

Compare LEXX & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.59

Market Cap

22.7M

Sector

Health Care

ML Signal

HOLD

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

HOLD

Current Price

$5.32

Market Cap

70.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEXX
VATE
Founded
2004
1994
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
22.7M
70.3M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
LEXX
VATE
Price
$0.59
$5.32
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
366.8K
30.3K
Earning Date
01-09-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$705,923.00
$1,099,900,000.00
Revenue This Year
$13.35
N/A
Revenue Next Year
$78.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
52.05
N/A
52 Week Low
$0.48
$4.05
52 Week High
$2.43
$13.79

Technical Indicators

Market Signals
Indicator
LEXX
VATE
Relative Strength Index (RSI) 28.90 59.25
Support Level $1.05 $4.16
Resistance Level $1.44 $5.49
Average True Range (ATR) 0.12 0.32
MACD -0.06 0.05
Stochastic Oscillator 10.94 87.22

Price Performance

Historical Comparison
LEXX
VATE

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

Share on Social Networks: